Tumor Marker Test Kits Market
Tumor marker test measures the amount of substances called tumor markers in tissue, blood, urine, ... Read More
Noninvasive prenatal testing (NIPT), sometimes called noninvasive prenatal screening (NIPS), is a method of determining the risk that the fetus will be born with certain genetic abnormalities. This testing analyzes small fragments of DNA that are circulating in a pregnant woman’s blood.
This report contains market size and forecasts of Noninvasive Prenatal Testing Service in Global, including the following market information:
Global Noninvasive Prenatal Testing Service Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Noninvasive Prenatal Testing Service market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
NIPT Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Noninvasive Prenatal Testing Service include Illumina, Natera, LifeLabs, NiftyTest, Labcorp, Xcelom, Veritas, Sema4 and CeGaT, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Noninvasive Prenatal Testing Service companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Noninvasive Prenatal Testing Service Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Noninvasive Prenatal Testing Service Market Segment Percentages, by Type, 2021 (%)
NIPT
NIPT Plus
Global Noninvasive Prenatal Testing Service Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Noninvasive Prenatal Testing Service Market Segment Percentages, by Application, 2021 (%)
Chromosomal Abnormalities
Assisted Reproduction
Others
Global Noninvasive Prenatal Testing Service Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Noninvasive Prenatal Testing Service Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Noninvasive Prenatal Testing Service revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Noninvasive Prenatal Testing Service revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Illumina
Natera
LifeLabs
NiftyTest
Labcorp
Xcelom
Veritas
Sema4
CeGaT
BGI
Berry Genomics
Daan Gene
CapitalBio
Annoroad
Adicon
Tumor marker test measures the amount of substances called tumor markers in tissue, blood, urine, ... Read More
Tumor Marker Test Kits in this report.
This report contains market size and forecas ... Read More
Cardiac markers are used in the diagnosis and risk stratification of patients with chest pain and ... Read More
Cardiac Marker Testing Kits in this report.
This report contains market size and fo ... Read More